Evidence map›Paper›PMID 35308043›Full record

ArticleMaterials today. Bio2022

Repair of osteochondral defects mediated by double-layer scaffolds with natural osteochondral-biomimetic microenvironment and interface.

Tao Wang, Wei Xu, Xintong Zhao, Baoshuai Bai, Yuejie Hua, Jincheng Tang, Feifan Chen, Yu Liu, Yahui Wang, Guangdong Zhou and 1 more

Abstract read
In one paragraph

Article in Materials today. Bio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Enhanced bone regeneration via local low-dose delivery of PTHFrontiers in bioengineering and biotechnology · 2023
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tao WangResearch Institute of Plastic Surgery, Wei Fang Medical University, Wei Fang, Shandong, 261041, PR China.
Wei XuResearch Institute of Plastic Surgery, Wei Fang Medical University, Wei Fang, Shandong, 261041, PR China.
Xintong ZhaoDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Tissue Engineering, Shanghai, 200011, PR China.
Baoshuai BaiResearch Institute of Plastic Surgery, Wei Fang Medical University, Wei Fang, Shandong, 261041, PR China.
Yuejie HuaDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Tissue Engineering, Shanghai, 200011, PR China.
Jincheng TangResearch Institute of Plastic Surgery, Wei Fang Medical University, Wei Fang, Shandong, 261041, PR China.
Feifan ChenResearch Institute of Plastic Surgery, Wei Fang Medical University, Wei Fang, Shandong, 261041, PR China.
Yu LiuDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Tissue Engineering, Shanghai, 200011, PR China.
Yahui WangNational Tissue Engineering Center of China, Shanghai, 200241, PR China.
Guangdong ZhouResearch Institute of Plastic Surgery, Wei Fang Medical University, Wei Fang, Shandong, 261041, PR China.
Yilin CaoResearch Institute of Plastic Surgery, Wei Fang Medical University, Wei Fang, Shandong, 261041, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue engineering provides a new approach for the treatment of osteochondral defects. However, the lack of an ideal double-layer scaffold with osteochondral-biomimetic microenvironment and interface similar to native articular tissue greatly limits clinical translation. Our current study developed a double-layer acellular osteochondral matrix (AOM) scaffold with natural osteochondral-biomimetic microenvironment and interface by integrating ultraviolet (UV) laser and decellularization techniques. The laser parameters were optimized to achieve a proper pore depth close to the osteochondral interface, which guaranteed complete decellularization, sufficient space for cell loading, and relative independence of the chondrogenic and osteogenic microenvironments. Gelatin-methacryloyl (GelMA) hydrogel was further used as the cell carrier to significantly enhance the efficiency and homogeneity of cell loading in the AOM scaffold with large pore structure. Additionally,

Indexed as

Acellular osteochondral matrixBiomimetic scaffoldHydrogelLaser technologyOsteochondral defect

Identifiers

PMID35308043
PMCPMC8924418

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.